0001231919-22-000052.txt : 20220804 0001231919-22-000052.hdr.sgml : 20220804 20220804123041 ACCESSION NUMBER: 0001231919-22-000052 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220804 DATE AS OF CHANGE: 20220804 EFFECTIVENESS DATE: 20220804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Addex Therapeutics Ltd. CENTRAL INDEX KEY: 0001574232 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-454872 FILM NUMBER: 221135631 BUSINESS ADDRESS: STREET 1: CHEMIN DES MINES 9 CITY: GENEVA STATE: V8 ZIP: CH-1202 BUSINESS PHONE: 01141228841555 MAIL ADDRESS: STREET 1: CHEMIN DES MINES 9 CITY: GENEVA STATE: V8 ZIP: CH-1202 D 1 primary_doc.xml X0708 D LIVE 0001574232 Addex Therapeutics Ltd. CHEMIN DES MINES 9 GENEVA V8 SWITZERLAND CH-1202 01141228841555 SWITZERLAND None None Corporation true Timothy Dyer c/o Addex Therapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Executive Officer Director Roger Mills c/o Addex Therapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Executive Officer Director Robert Lutjens c/o Addex Therapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Executive Officer Jean-Philippe Rocher c/o Addex Therapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Executive Officer Mikhail Kalinichev c/o Addex Therapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Executive Officer Vincent Lawton c/o Addex Therapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Director Jake Nunn c/o NEA Enterprise Associates 2855 Sand Hill Road Menlo Park CA CALIFORNIA 94025 Director Raymond Hill c/o AddexTherapeutics Ltd. Chemin des Mines 9 Geneva V8 SWITZERLAND CH-1202 Director Isaac Manke c/o Acorn Bioventures 420 Lexington Avenue, Suite 2626 New York NY NEW YORK 10170 Director Biotechnology Decline to Disclose 06b false 2022-07-22 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 NY NEW YORK false 4230500 4230500 0 Represents amounts receivable upon full-exercise of warrants to purchase ADS; such warrants have not yet been exercised. false 1 285558 0 0 false Addex Therapeutics Ltd. /s/ Timothy Dyer Timothy Dyer Chief Executive Officer 2022-08-04